100 Clinical Results associated with GL Synthesis, Inc.
0 Patents (Medical) associated with GL Synthesis, Inc.
Current Opinion in Anti-Infective Investigational Drugs
Status of inhibitors of herpes simplex thymidine kinases
Author: Gambino, Joseph J. ; Wright, George E. ; Gebhardt, Bryan M. ; Sun, Hongmao
A review with 23 references Determination of the crystal structures of complexes of herpes simplex virus type 1 thymidine kinase (HSV1 TK) with its substrates has provided a detailed picture of the active site and an understanding of the wide substrate range of the enzyme.The binding mode of a class of nonsubstrate inhibitors, exemplified by 9-(4-hydroxybutyl)-N2-phenylguanine (HBPG), has been revealed in the crystal structure of the TK:HBPG complex, allowing rational design of improved inhibitors.Further studies of the effect of HBPG in a murine model of HSV1 latency demonstrated the promise of TK inhibitors in preventing reactivation of herpetic diseases.
Current Opinion in Anti-Infective Investigational Drugs
DNA polymerase III: a new target for antibiotic development
Author: Brown, Neal C. ; Wright, George E.
A review with 15 referencesThere is a rapidly growing crisis in the management of life-threatening disease caused by multi-antibiotic-resistant bacteria.One approach to this problem is the identification of new antibiotic targets and the development of target-selective bullets.A promising unexploited target, the bacterial DNA polymerase III (pol III) is discussed in this review.
100 Deals associated with GL Synthesis, Inc.
100 Translational Medicine associated with GL Synthesis, Inc.